LUGANO, SWITZERLAND—Sarah Maxwell and Peter Goodwin report from the 2013 European Multidisciplinary Conference on Thoracic Oncology:
Biomarkers: new drug targets in adenocarcinoma of the lung
Professor Ken O’Byrne, St James’s Hospital and Trinity College, Dublin.
Emerging targetable biomarkers for squamous cell carcinoma
Dr Martin Edelman, University of Maryland School of Medicine, Baltimore.
Centrally located tumors: control vs. toxicity
Dr Suresh Senan, VU University Medical Center, Amsterdam.
Tailored chemo-radiotherapy: maximize effect; minimize tissue damage
Dirk De Ruysscher, Maastricht University Medical Center, Netherlands.
PET-CT guidance for treating nodules helps avoid overtreatment
Dr Barbara Malene Fischer, Copenhagen University.
Immune therapies restore tissue immunity to fight cancer
Professor Martin Reck, Grosshansdorf Hospital, Hamburg